Histopathologic quality of prostate core biopsy specimens: Comparison of an MR-compatible biopsy needle and a ferromagnetic biopsy needle used for ultrasound-guided prostate biopsy;Histopathologische qualität von prostatastanzzylindern: Vergleich einer MR-kompatiblen biopsienadel mit einer im ultraschall eingesetzten ferromagnetischen biopsienadel

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 178, Issue 12, 2006, Pages 1212-1218

  Franiel, Tobias ^a   Fritzsche, F ^a   Staack, A ^a   Rost, J ^b   Hamm, B ^a   Beyersdorff, D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institut für Gynäkologie und Geburtshilfe   (Germany)

Author keywords

Biopsy prostate; MR imaging

Indexed keywords

FERROMAGNETIC MATERIAL; PROSTATE SPECIFIC ANTIGEN; TITANIUM; FERRIC ION; STAINLESS STEEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HISTOCOMPATIBILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; SCORING SYSTEM; ULTRASOUND; BLOOD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ECHOGRAPHY; INSTRUMENTATION; MIDDLE AGED; NEEDLE; NEEDLE BIOPSY; PATHOLOGY; PROSTATE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

AGED; BIOPSY, NEEDLE; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEEDLES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; RETROSPECTIVE STUDIES; STAINLESS STEEL; TITANIUM;

EID: 33846959124     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926936     Document Type: Article

References (28)

1. Catalona WJ, Smith DS, Ratliff TL et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-1161
2. Urologie AL. PSA-Bestimmung in der Prostatakarzinomdiagnostik.; www.uni-duesseldorf.de/WWW/AWMF/ll/ll_list.htm2003.
3. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994; 151: 1571-1574
4. Roehl KA, Antenor JA, Catalona WJ. Serial biopsy results in prostate cancer screening study. J Urol 2002; 167: 2435-2439
5. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 2004; 24: S167-180
6. Gemeinhardt O, Ludemann L, Prochnow D et al. Differenzierung des Prostatakarzinoms gegenüber normalem Drüsengewebe der Prostata am Tiermodell: konventionelle MRT-Bildgebung und dynamische kontrastmittelunterstützte MRT. Fortschr Röntgenstr 2005; 177: 935-939
7. Kiessling F, Lichy M, Grobholz R et al. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI. Eur Radiol 2004; 14: 1793-1801
8. Kurhanewicz J, Vigneron DB, Males RG et al. The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin North Am 2000; 38: 115-138, vii-ix
9. Kemper J, Sinkus R, Lorenzen J et al. MR-Elastographie der Prostata: Erste In-vivo-Anwendung. Fortschr Röntgenstr 2004; 176: 1094-1099
10. Schlemmer HP, Merkle J, Grobholz R et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol 2004; 14: 309-317
11. Perrotti M, Han KR, Epstein RE et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 1999; 162: 1314-1317
12. Wetter A, Ajdukovic AN, Fliessbach K et al. Wertigkeit der kombinierten Information aus endorektaler MRT, bioptischem Gleason Score und präoperativem PSA-Wert. Fortschr Röntgenstr 2006; 178: 385-390
13. Beyersdorff D, Taupitz M, Winkelmann B et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002; 224: 701-706
14. Beyersdorff D, Hamm B. MRT zur Problemlösung beim Nachweis des Prostatakarzinoms. Fortschr Röntgenstr 2005; 177: 788-795
15. Beyersdorff D, Winkel A, Hamm B et al. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 2005; 234: 576-581
16. Engelhard K, Hollenbach HP, Kiefer B et al. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 2006; 16: 1-7
17. D'Amico AV, Tempany CM, Cormack R et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000; 164: 385-387
18. Zangos S, Eichler K, Engelmann K et al. MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results. Eur Radiol 2005; 15: 174-182
19. Langen HJ, Kugel H, Ortmann M et al. Funktionsfâhigkeit MR-kompatibler Biopsienadeln im Vergleich zu ferromagnetischen Biopsienadeln. Invitro-Untersuchungen. Fortschr Röntgenstr 2001; 173: 658-662
20. Hopper KD, Abendroth CS, Sturtz KW et al. Automated biopsy devices: a blinded evaluation. Radiology 1993; 187: 653-660
21. Hopper KD, Abendroth CS, Sturtz KW et al. Blinded comparison of biopsy needles and automated devices in vitro: 1. Biopsy of diffuse hepatic disease. AJR 1993; 161: 1293-1297
22. Parkkola RK, Mattila KT, Heikkila JT et al. MR-guided core biopsies of soft tissue tumours on an open 0.23 T imager. Acta Radiol 2001; 42: 302-305
23. Hopper KD, Abendroth CS, Sturtz KW et al. Blinded comparison of biopsy needles and automated devices in vitro: 2. Biopsy of medical renal disease. AJR 1993; 161: 1299-1301
24. Davison P, Malament M. Urinary contamination as a result of transrectal biopsy of the prostate. J Urol 1971; 105: 545-546
25. Fawcett DP, Eykyn S, Bultitude MI. Urinary tract infection following trans-rectal biopsy of the prostate. Br J Urol 1975; 47: 679-681
26. Wendel RG, Evans AT. Complications of punch biopsy of the prostate gland. J Urol 1967; 97: 122-126
27. Sika JV, Lindquist HD. Relationship of needle biopsy diagnosis of prostate to clinical signs of prostatic cancer: an evaluation of 300 cases. J Urol 1963; 89: 737-745
28. Bostwick DG. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 1994; 18: 796-803